ADC |
antibody-drug conjugate |
ADCC |
antibody-dependent cytotoxicity |
APRIL |
A proliferation-inducing ligand |
BCMA |
B cell maturation antigen |
BM |
bone marrow |
BMME |
bone marrow microenvironment |
Breg |
regulatory B cell |
BsAb |
bispecific antibody |
CAR |
chimeric antigen receptor |
CR |
complete response |
CRAB |
hypercalcemia (C), renal failure (R), anemia (A), bone lesions (B) |
CRS |
cytokine release syndrome |
CTL |
cytotoxic T lymphocytes |
CTLA-4 |
cytotoxic T-lymphocyte-associated protein 4 |
DC |
dendritic cell |
EMD |
extra-medullary disease |
FDA |
food and drug administration |
FOXP3 |
forkhead box P3 |
GC |
germinal center |
GvHD |
graft-versus-host-disease |
HLA |
human leukocyte antigen |
ICAM-1 |
intercellular Adhesion Molecule 1 |
IDO |
indoleamine 2,3-dioxygenase |
IFN |
Interferon |
Ig |
immunoglobulin |
IL |
interleukin |
IMiDs |
immunomulatory drugs |
LAG-3 |
lymphocyte-activation gene 3 |
mAb |
monoclonal antibody |
MDSC |
myeloid-derived suppressor cells |
MGUS |
monoclonal gammopathy of undetermined significance |
MHC |
major histocompatibility complex |
MM |
multiple myeloma |
MMAF |
monomethyl auristatin F |
mOS |
median overall survival |
MRD |
minimal residual disease |
MSC |
mesenchymal stromal cell |
NDMM |
newly diagnosed multiple myeloma |
NGS |
next-generation sequencing |
NO |
nitric oxide |
NR |
not reported |
NTE |
not transplant eligible |
ORR |
overall response rate |
PD-1 |
programmed cell death protein 1 |
PD-L1/2 |
programmed cell death protein 1 ligand 1/2 |
PGE2 |
prostaglandin E2 |
PI |
proteasome inhibitor |
ROS |
reactive oxygen species |
RRMM |
relapsed/refractory multiple myeloma |
sFLC |
serum free light chain |
SMM |
smouldering multiple myeloma |
STAT3 |
signal transducer and activator of transcription 3 |
TACI |
transmembrane activator, and calcium modulator and cyclophilin ligand interactor |
TAM |
tumor-associated macrophage |
TAM |
tumor-associated macrophage |
TE |
transplant eligible |
TGF-β |
transforming growth factor beta |
Th |
T helper cell |
TIGIT |
T cell immunoglobulin and ITIM domain |
TIM-3 |
T cell immunoglobulin mucin-3 |
Treg |
regulatory T cell |
TRL4 |
toll-like receptor 4 |
VCAM-1 |
vascular cell adhesion molecule 1 |
VEGF |
vascular endothelial growth factor |
VGPR |
very good partial response |